ZETADENT Trademark

Trademark Overview

On Monday, April 18, 2022, a trademark application was filed for ZETADENT with the United States Patent and Trademark Office. The USPTO has given the ZETADENT trademark a serial number of 97367624. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, October 10, 2025. This trademark is owned by Zetagen Therapeutics, Inc.. The ZETADENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of bone diseases
zetadent

General Information

Serial Number97367624
Word MarkZETADENT
Filing DateMonday, April 18, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, October 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of bone diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZetagen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210
Party NameZetagen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSyracuse, NY 13210

Trademark Events

Event DateEvent Description
Friday, April 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2022NEW APPLICATION ENTERED
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 13, 2023SOU EXTENSION 1 FILED
Monday, March 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 2 FILED
Thursday, September 14, 2023SOU EXTENSION 2 GRANTED
Saturday, September 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023ASSIGNED TO EXAMINER
Tuesday, February 20, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 20, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 20, 2024SOU EXTENSION 3 FILED
Wednesday, February 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 21, 2024SOU EXTENSION 4 FILED
Wednesday, August 21, 2024SOU EXTENSION 4 GRANTED
Friday, October 10, 2025ABANDONMENT - NO USE STATEMENT FILED
Friday, October 10, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, August 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

zetadent diseases bone treatment products pharmaceutical